Wolters Kluwer (ENXTAM:WKL) Extends Norway Deal And AI Pilot, Is The Discount Too Deep?
Wolters Kluwer (ENXTAM:WKL) is back in focus after Norway’s national health system renewed and expanded its UpToDate clinical decision support agreement and agreed to pilot the company’s new AI powered Expert AI tool.
See our latest analysis for Wolters Kluwer.
Those contract renewals and AI pilots come after a tough stretch for Wolters Kluwer shareholders, with the share price falling over the year despite a recent 1 month share price return of 11.02% and a 1 day gain of 4.52%, while the 1 year total shareholder return is down 51.85%.
If you are looking beyond Wolters Kluwer for other AI driven opportunities in your portfolio, it could be a good moment to scan the market using the 128 healthcare AI stocks
The stock now trades at a steep discount to both analyst targets and one intrinsic value estimate after that sharp slide and recent bounce. Is the market prudently cautious on Wolters Kluwer, or mispricing its prospects?
Most Popular Narrative: 13% Undervalued
The most followed narrative on Wolters Kluwer values the stock at €71.44 per share versus the last close of €62.46, framing the recent sell off as a potential opportunity rather than a permanent reset.
Wolters Kluwer is not just a generic information provider. It operates in professional niches where reliability, regulatory accuracy, embedded workflows, and trusted content matter a lot. That gives it some protection, because customers in legal, tax, compliance, and healthcare do not switch lightly.
This narrative, according to Metuendus, leans heavily on steady earnings, durable margins, and a valuation multiple that assumes those cash flows keep compounding in the background. It raises the question of which long term profit and revenue assumptions have been used to reach that €71.44 fair value and how they compare to more growth focused stocks.
Result: Fair Value of €71.44 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on Wolters Kluwer continuing to defend its niches against AI competitors and maintaining current revenue and profit levels if customer budgets tighten.
Find out about the key risks to this Wolters Kluwer narrative.
Next Steps
If the mixed sentiment around Wolters Kluwer leaves you undecided, take a closer look at both sides of the story and form your own stance quickly by reviewing the 5 key rewards and 1 important warning sign
Looking for more investment ideas beyond Wolters Kluwer?
If Wolters Kluwer has sharpened your focus on quality, do not stop here. The wider market still holds plenty of under the radar opportunities worth your attention.
- Spot potential value with staying power by scanning companies that look mispriced on quality and fundamentals through the 247 high quality undervalued stocks
- Strengthen your income stream by reviewing the 458 dividend fortresses that could support regular cash returns while you hold.
- Dial down portfolio stress by focusing on resilient companies using the 294 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com